Compare The Coca-Cola Co K (KO) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
The Coca-Cola Co K vs NeoGenomics Inc. Common Stock — how do they compare? The Coca-Cola Co K trades at $92.84 (market cap $387.70B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B). The key difference: The Coca-Cola Co K is far larger — about 181.2× NeoGenomics Inc. Common Stock's market cap, and The Coca-Cola Co K pays a 2.35% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold The Coca-Cola Co K for 154 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| KO | NEO | |
|---|---|---|
Market Cap | $387.70B | $2.14B |
Volume | 15,313,783 | 2,228,400 |
Sector | Consumer Staples | Health |
52-Week High | $91.99 | $19.91 |
52-Week Low | $67.08 | $7.19 |
Typical Hold Time | 154 Days | 0 Days |
Enterprise Value | $414.87B | $2.44B |
Dividend Yield | 2.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $90.11, up 0.36% with strong technical momentum as it approaches resistance near $91. The company demonstrates robust fundamentals with Q2 2026 EPS of $0.97 beating expectations, maintaining a 61.89% gross margin and 28.56% net margin. Recent institutional buying activity and the upcoming $0.53 dividend payment reflect positive sentiment. The stock trades at a P/E of 27.06, above sector averages, while analyst consensus targets $95.75 with 60% buy ratings.
Outlook remains favorable with projected 2026 revenue growth to $50.1B and net income of $14.3B. Key risks include high valuation multiples and regional demand divergence. The technical setup suggests near-term consolidation with support at $88, while fundamental strength supports long-term dividend growth potential.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
